Dear Friends and Colleagues,
It is our great pleasure to invite you to the Membrane Trafficking and Organelle Biogenesis Meeting (MTOB), which will be held in Sorrento from 14 to 15 October 2018.
As is the tradition, the meeting will bring together experimental scientists to focus on recent advances in organelle structure, function and biogenesis, protein trafficking, exo-endocytosis, autophagy and lipid biology.
As a keynote invited speaker, we will host Ludger Johannes , Research Director at INSERM. Since 2001, he is heading the Traffic, Signaling and Delivery Group in the Cell Biology Department of the Curie Institute, Paris, France. His research aims at establishing fundamental concepts of endocytosis and intracellular trafficking. The Johannes group has made various major contributions in the field of endocytosis. His research is remarkable for the advanced imaging tools he exploits to remain at the forefront of science.
The date and setting of the conference have been chosen such that participants may combine their travel arrangements, as immediately after our meeting at the same venue the FEBS Golgi meeting will be held. Junior scientists (under 35 years) who will attend both meetings are eligible for an ABCD-sponsored travel fellowship. Awardees will be notified at least a month in advance of the meetings.
We hope that the meeting will provide a great opportunity to share new ideas, foster collaborations, and encourage young researchers in the field.
We are very much looking forward to welcoming you to Sorrento in October.
Eelco van Anken & Simona Paladino
Eelco van Anken
The Abstracts book is available through your personal myMTOB area, (myDocs tab).
Registrations & Abstracts:
7 September 2018
Ludger Johannes (Ph.D.) is Research Director (DRE) at INSERM. Between 2001 and 2013, he directed the Traffic, Signaling and Delivery Group in the Cell Biology Department (UMR144 CNRS) of Institut Curie. Since January 2014, he is heading the Chemical Biology of Membranes and Therapeutic Delivery unit (U1143 INSERM — UMR3666 CNRS). His research aims at establishing fundamental concepts of endocytosis and intracellular trafficking. The Johannes group has made two major contributions in this context: the discovery of a membrane trafficking interface between early endosomes and the Golgi apparatus, and the demonstration that dynamic lectin-induced glycosphingolipid reorganization acts as a driving force for endocytic pit construction in clathrin-independent endocytosis. These studies are highly cited and have been published in several high-ranking journals, including Cell, Nature, Nature Cell Biology, and Nature Nanotechnology. He also aims at exploiting these discoveries in fundamental membrane biology research for the development of innovative cancer therapy strategies. His basic studies have allowed him to validate the B-subunit of Shiga toxin (STxB) as a "pilot" for the delivery of therapeutic compounds to precise intracellular locations of dendritic and tumor cells, leading to several patents.